Bertoni Serena, Albertini Beatrice, Passerini Nadia
Department of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, Via S. Donato 19/2, 40127 Bologna, Italy.
Pharmaceutics. 2020 Jun 12;12(6):548. doi: 10.3390/pharmaceutics12060548.
Delivery of poorly water soluble active pharmaceutical ingredients (APIs) by semi-crystalline solid dispersions prepared by spray congealing in form of microparticles (MPs) is an emerging method to increase their oral bioavailability. In this study, solid dispersions based on hydrophilic Gelucires (Gelucire 50/13 and Gelucire 48/16 in different ratio) of three BCS class II model compounds (carbamazepine, CBZ, tolbutamide, TBM, and cinnarizine, CIN) having different physicochemical properties (logP, pKa, Tm) were produced by spray congealing process. The obtained MPs were investigated in terms of morphology, particles size, drug content, solid state properties, drug-carrier interactions, solubility, and dissolution performances. The solid-state characterization showed that the properties of the incorporated drug had a profound influence on the structure of the obtained solid dispersion: CBZ recrystallized in a different polymorphic form, TBM crystallinity was significantly reduced as a result of specific interactions with the carrier, while smaller crystals were observed in case of CIN. The in vitro tests suggested that the drug solubility was mainly influenced by carrier composition, while the drug dissolution behavior was affected by the API solid state in the MPs after the spray congealing process. Among the tested APIs, TBM-Gelucire dispersions showed the highest enhancement in drug dissolution as a result of the reduced drug crystallinity.
通过喷雾冷凝法制备微粒(MPs)形式的半结晶固体分散体来递送难溶性活性药物成分(APIs),是一种提高其口服生物利用度的新兴方法。在本研究中,通过喷雾冷凝法制备了基于三种具有不同理化性质(logP、pKa、Tm)的BCS II类模型化合物(卡马西平,CBZ;甲苯磺丁脲,TBM;桂利嗪,CIN)的亲水性Gelucires(不同比例的Gelucire 50/13和Gelucire 48/16)的固体分散体。对所得的MPs进行了形态、粒径、药物含量、固态性质、药物-载体相互作用、溶解度和溶出性能等方面的研究。固态表征表明,所包载药物的性质对所得固体分散体的结构有深远影响:CBZ以不同的多晶型形式重结晶,TBM由于与载体的特定相互作用结晶度显著降低,而CIN则观察到较小的晶体。体外试验表明,药物溶解度主要受载体组成的影响,而药物溶出行为则受喷雾冷凝过程后MPs中API固态的影响。在所测试的API中,TBM-Gelucire分散体由于药物结晶度降低而表现出最高的药物溶出增强效果。